Term ended Nov 2, 2026 · Low confidence
20-year base term ended Nov 2, 2026
Filed May 21, 2015 as application 14/719,015 · Granted May 3, 2016
Base term, 20 years from filing
Today
Term ended Nov 2, 2026
2006
2026
Clock starts
Nov 2, 2006
Nov 2, 2006
Term ended
Nov 2, 2026
Nov 2, 2026
Granted
May 3, 2016
May 3, 2016
base term
after the term ends
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,586,045, US 8,734,802, to Nov 2, 2026. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
22
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 2, 2006, when application PCT/IB2006/003181, the earliest non-provisional in its chain, was filed (this one was filed May 21, 2015); a parent in its chain could not be resolved (the next row) | Nov 2, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,586,045, US 8,734,802) | resolves to Nov 2, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Further caveats on record | The record names parents not resolved: 13835394, 13835394, 13835394 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Nov 2, 2026 | Low confidence |
Partial family
| Application PCT/IB2006/003181 | PCT application no patent term | no patent term |
| US 8,007,794 | In force Jun 2031 | Jun 2031 |
| US 8,586,045 | Term ended Nov 2026 | Nov 2026 |
| Application 13/835,394 | Abandoned not computed | not computed |
| US 8,597,649 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,734,802 | Term ended Nov 2026 | Nov 2026 |
| US 9,115,194 | Term ended Nov 2026 | Nov 2026 |
| US 9,328,168 | this patent Nov 2026 | Nov 2026 |
8 of 22 applications in this family shown, earliest filings first. Partial: 1 of the 22 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 22, 2015 Reel 35702, frame 836 | Zeller, Jorg; Poulsen, Kristian T.; Abdiche, Yasmina N.; Pons, Jaume; Jones, Sierra L.; Rosenthal, Arnon | Rinat Neuroscience Corp. | Assignment of Assignor's Interest |
| May 26, 2015 Reel 35711, frame 607 | Rinat Neuroscience Corp. | Labrys Biologics, Inc. | Assignment of Assignor's Interest |
| Oct 21, 2016 Reel 40449, frame 698 | Labrys Biologics, Inc. | Teva Pharmaceuticals International GmbH | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,586,045, US 8,734,802, ends no earlier than this term, so it caps nothing.
Citations
32
later US patents cite this one
That is top 25% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.